n-hydroxy-4-phosphonobutanamide has been researched along with Fatty Liver in 1 studies
*Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, RC; Byun, JH; Faiyaz, M; Lebeau, PF; MacDonald, ME; Platko, K; Poon, SV; Seidah, NG | 1 |
1 other study(ies) available for n-hydroxy-4-phosphonobutanamide and Fatty Liver
| Article | Year |
|---|---|
Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing
Topics: Animals; Apolipoproteins B; Cholesterol, LDL; Diet, High-Fat; Endoplasmic Reticulum Stress; Fatty Liver; Hep G2 Cells; Humans; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Organophosphorus Compounds; Proprotein Convertase 9; Receptors, LDL; Sterol Regulatory Element Binding Protein 2 | 2019 |